ArticleGels (Basel, Switzerland)2026
Organic-Inorganic Hyaluronic Acid/Sumecton Nanocomposite Hydrogels for Osteogenic Applications.
Article in Gels (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
While their biocompatibility and extracellular matrix-mimetic properties make hyaluronic acid (HA)-based hydrogels attractive biomaterials for bone regenerative applications, their limited mechanical stability and insufficient osteogenic activity restrict broader utility. Here, we present an organic-inorganic nanocomposite hydrogel integrating catechol-functionalized HA with Sumecton clay (SU) nanosheets as multifunctional inorganic junction domains. Oxidative crosslinking of dopamine-functionalized HA established the primary hydrogel network, while the resulting hybrid network exhibited injectability and structural recovery following deformation. Incorporation of 2% SU increased the compressive modulus from approximately 4.6 to 6.0 kPa and delayed hydrogel degradation, while only modestly affecting equilibrium water content. The hybrid hydrogels also exhibited antimicrobial and catechol-mediated antioxidant activities, establishing a multifunctional microenvironment suited to tissue regeneration. SU-containing hydrogels promoted the osteogenic differentiation of encapsulated stem cells, as evidenced by increased alkaline phosphatase activity and matrix mineralization. SAG was incorporated into SU with a loading efficiency of approximately 95%, and SU@SAG-containing hydrogels further enhanced osteogenic differentiation and mineralization. Gene expression analysis showed increased expression of Hedgehog-associated markers together with modulation of Wnt/β-catenin-related genes, suggesting signaling responses associated with enhanced osteogenesis. Collectively, this study demonstrates an organic-inorganic network engineering strategy to develop structurally robust and biologically functional HA-based nanocomposite hydrogels for bone regenerative applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.